These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 15812216
41. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T. APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [Abstract] [Full Text] [Related]
42. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC, van de Rijn M, Brooks JD. Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [Abstract] [Full Text] [Related]
43. Clinical significance of denuded urothelium in bladder biopsy. Levi AW, Potter SR, Schoenberg MP, Epstein JI. J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047 [Abstract] [Full Text] [Related]
44. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. Barbisan F, Santinelli A, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, van der Kwast T, Montironi R. Cancer; 2008 Feb 01; 112(3):636-44. PubMed ID: 18072261 [Abstract] [Full Text] [Related]
45. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Wasco MJ, Daignault S, Bradley D, Shah RB. Hum Pathol; 2010 Feb 01; 41(2):163-71. PubMed ID: 19800100 [Abstract] [Full Text] [Related]
46. [Inverted urothelial papilloma]. Bar-Moshe O, De Roy G, Vandendris M. J Urol (Paris); 1983 Feb 01; 89(1):35-8. PubMed ID: 6841989 [Abstract] [Full Text] [Related]
47. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E. Hum Pathol; 2005 Aug 01; 36(8):899-907. PubMed ID: 16112007 [Abstract] [Full Text] [Related]
48. [So-called benign papilloma of the bladder. A retrospective study]. Flamm J. Wien Med Wochenschr; 1985 Feb 28; 135(4):93-5. PubMed ID: 3993047 [Abstract] [Full Text] [Related]
49. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage. Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G. Eur Urol; 2008 Sep 28; 54(3):612-20. PubMed ID: 17977643 [Abstract] [Full Text] [Related]
50. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD, Sagalowsky AI. Cancer; 2000 May 15; 88(10):2333-41. PubMed ID: 10820356 [Abstract] [Full Text] [Related]
51. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI. J Urol; 2005 Nov 15; 174(5):1976-80. PubMed ID: 16217372 [Abstract] [Full Text] [Related]
52. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma. Mineta H, Miura K, Takebayashi S, Misawa K, Araki K, Misawa Y, Ueda Y. Anticancer Res; 2002 Nov 15; 22(6B):3489-94. PubMed ID: 12552944 [Abstract] [Full Text] [Related]
53. Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome. Mylona E, Giannopoulou I, Diamantopoulou K, Bakarakos P, Nomikos A, Zervas A, Nakopoulou L. Eur J Surg Oncol; 2009 Feb 15; 35(2):197-201. PubMed ID: 18513919 [Abstract] [Full Text] [Related]
54. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. Oliveira PA, Colaço A, De la Cruz LF, Lopes P, Lopes C. J Exp Clin Cancer Res; 2006 Sep 15; 25(3):425-32. PubMed ID: 17167984 [Abstract] [Full Text] [Related]
55. Clinical characteristics of bladder urothelial tumors in female patients. Zhang NZ, Chen J, Wang HQ, Xu ZS. Menopause; 2010 Mar 15; 17(2):421-5. PubMed ID: 19713871 [Abstract] [Full Text] [Related]
56. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Lee TK, Chaux A, Karram S, Miyamoto H, Miller JS, Fajardo DA, Epstein JI, Netto GJ. Hum Pathol; 2011 Nov 15; 42(11):1799-803. PubMed ID: 21777949 [Abstract] [Full Text] [Related]
57. Evaluation of urinary inverted papillomas: a report of 13 cases and literature review. Kilciler M, Bedir S, Erdemir F, Ors O, Kibar Y, Dayanc M. Kaohsiung J Med Sci; 2008 Jan 15; 24(1):25-30. PubMed ID: 18218566 [Abstract] [Full Text] [Related]
58. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder. Gunia S, Kakies C, May M, Koch S, Erbersdobler A. J Clin Pathol; 2011 Aug 15; 64(8):672-6. PubMed ID: 21512109 [Abstract] [Full Text] [Related]
59. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT. Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4400-6. PubMed ID: 17671122 [Abstract] [Full Text] [Related]
60. Nest-like features in bladder, simulating the nested variant of urothelial carcinoma. Patriarca C, Colecchia M, Lopez-Beltran A, Sirugo G, Di Pasquale M, Bollito E. Int J Surg Pathol; 2011 Feb 01; 19(1):11-9. PubMed ID: 20034978 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]